Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-12
2007-06-12
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S424000, C549S425000
Reexamination Certificate
active
10494241
ABSTRACT:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2is acetyl or trifluoroacetyl; and n is an integer from 10 to 18 or a pharmaceutically acceptable derivative thereof, methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection
REFERENCES:
patent: WO 00/55149 (2000-09-01), None
patent: WO 02/20514 (2002-03-01), None
Fleming,DM Managing influenza: amantadine, rimantadine and beyond, PMID: 11351773, (2001).
Demaine Derek A.
Inglis Graham G. A.
MacDonald Simon J. F.
Shanahan Stephen E.
Tucker Simon P.
Biota Scientific Management Pty Ltd.
Foley & Lardner LLP
Owens Amelia A.
LandOfFree
Dimeric compounds and their use as anti-viral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimeric compounds and their use as anti-viral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimeric compounds and their use as anti-viral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836691